Editorial
Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?
Muscle & Nerve · 2024
DOI: 10.1002/mus.28107 ↗Kurz gefasst
Editorial in der Zeitschrift Muscle & Nerve, 2024. Verfasst von W Bryan Burnette. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Muscular Dystrophy, DuchenneHumansMorpholinosMaleChildSteroids
Substanzen
eteplirsenMorpholinosSteroids
Autor:innen und Institutionen
- Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: W Bryan Burnette
Zitieren
APA
Burnette, W. B. (2024). Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. https://doi.org/10.1002/mus.28107
Vancouver
Burnette WB. Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. 2024. doi:10.1002/mus.28107
BibTeX
@article{Burnette2024,
author = {Burnette, W Bryan},
title = {Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?},
journal = {Muscle & Nerve},
year = {2024},
doi = {10.1002/mus.28107}
}
EUVIMED